Acusphere Secures Funding From Cephalon To See Imagify Through PDUFA
This article was originally published in The Pink Sheet Daily
Executive Summary
Cephalon gains option to license the cardiovascular imaging drug, as well as rights to an injectable formula of celecoxib in preclinical development.